Profil
Nadia F.
Altomare is currently the Director at Savran Technologies, Inc. and Patient Rights Advocate, Inc. She was previously the CEO & Director at Abcodia Ltd., Vice President & General Manager at Revvity, Inc., VP & General Manager-Global DNA Analysis at Thermo Fisher Scientific, Inc., and is set to be the Chief Commercial Officer at Sera Prognostics, Inc. until 2023.
Altomare holds an undergraduate degree from Stony Brook University and an MBA from Northeastern University.
Postes actifs de Nadia Altomare
| Sociétés | Poste | Début |
|---|---|---|
Savran Technologies, Inc.
Savran Technologies, Inc. BiotechnologyHealth Technology Develops and provides non-invasive diagnostics based on capture & analysis of rare cells | Directeur/Membre du Conseil | - |
Patient Rights Advocate, Inc.
Patient Rights Advocate, Inc. Patient Rights Advocate, Inc. is a nonprofit organization dedicated to promoting healthcare price transparency to empower patients, consumers, employers, and other stakeholders. The private company is based in Newton, MA. The organization provides free online tools, such as state-specific hospital price finder platforms and a nationwide hospital drug price finder, which display negotiated rates, cash prices, and procedure-specific cost information sourced from CMS-mandated data. These tools help users compare hospital prices, identify overcharges, and make informed healthcare decisions to avoid surprise billing and reduce medical costs. The organization focuses on driving systemic change toward fair, upfront medical pricing by educating the public, debunking myths about healthcare pricing, and advocating for policies that enhance transparency and competition. It offers resources on how to shop for healthcare, fight medical bill overcharges, and navigate billing disputes, encouraging patients to verify charges, negotiate costs, and engage with providers and insurers. Patient Rights Advocate also conducts research, publishes reports on hospital pricing compliance, supports legal actions against inflated drug costs, and participates in public policy advocacy to foster a competitive healthcare market that improves quality and affordability. The company was founded in 2017 by Cynthia A. Fisher. | Directeur/Membre du Conseil | - |
Anciens postes connus de Nadia Altomare
| Sociétés | Poste | Fin |
|---|---|---|
| SERA PROGNOSTICS, INC. | Corporate Officer/Principal | 09/06/2023 |
Abcodia Ltd.
Abcodia Ltd. BiotechnologyHealth Technology Engages in validation and discovery of molecular biomarkers | Directeur Général | 01/05/2017 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01/01/2014 |
| REVVITY, INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Nadia Altomare
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Stony Brook University
Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Sera Prognostics, Inc.
Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Abcodia Ltd.
Abcodia Ltd. BiotechnologyHealth Technology Engages in validation and discovery of molecular biomarkers | Health Technology |
Savran Technologies, Inc.
Savran Technologies, Inc. BiotechnologyHealth Technology Develops and provides non-invasive diagnostics based on capture & analysis of rare cells | Health Technology |
Patient Rights Advocate, Inc.
Patient Rights Advocate, Inc. Patient Rights Advocate, Inc. is a nonprofit organization dedicated to promoting healthcare price transparency to empower patients, consumers, employers, and other stakeholders. The private company is based in Newton, MA. The organization provides free online tools, such as state-specific hospital price finder platforms and a nationwide hospital drug price finder, which display negotiated rates, cash prices, and procedure-specific cost information sourced from CMS-mandated data. These tools help users compare hospital prices, identify overcharges, and make informed healthcare decisions to avoid surprise billing and reduce medical costs. The organization focuses on driving systemic change toward fair, upfront medical pricing by educating the public, debunking myths about healthcare pricing, and advocating for policies that enhance transparency and competition. It offers resources on how to shop for healthcare, fight medical bill overcharges, and navigate billing disputes, encouraging patients to verify charges, negotiate costs, and engage with providers and insurers. Patient Rights Advocate also conducts research, publishes reports on hospital pricing compliance, supports legal actions against inflated drug costs, and participates in public policy advocacy to foster a competitive healthcare market that improves quality and affordability. The company was founded in 2017 by Cynthia A. Fisher. |
















